share_log

同仁堂国药发布2023年度业绩 股东应占利润5.4亿港元同比减少16.3%

Tong Ren Tang Sinopharm Announces 2023 Annual Results Profit attributable to shareholders of HK$540 million, a decrease of 16.3% year-on-year

新浪港股 ·  Mar 14 21:01

Tong Ren Tang Sinopharm (03613) announced its results for the year ended December 31, 2023. The group achieved revenue of HK$1,525 million, a year-on-year decrease of 11.9%; profit attributable to company owners of HK$540 million, a year-on-year decrease of 16.3%; basic profit per share of HK$0.65; and proposed to pay a final dividend of HK$0.33 per common share.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment